Author: Edit Urbán
View More View Less
  • 1 University of Szeged Institute of Clinical Microbiology, Faculty of Medicine Szeged Hungary
  • 2 University of Szeged Institute of Clinical Microbiology, Faculty of Medicine Szeged H-6701 P.O. Box 427 Hungary
Open access

In spite of the developments in microbiological methods, blood cultures remain the cornerstone for the diagnosis of bacteraemia. Classically, minimum of two bottles are collected on a routine basis: an aerobic bottle, allowing preferential growth of aerobic and facultative anaerobic microorganisms, and an anaerobic bottle, providing suitable environment for strict anaerobic bacteria. Recent reports have documented a decrease in anaerobic bacteraemias and have questioned the need for routine anaerobic blood cultures. Bacteraemia due to anaerobic organisms occurs in 0.5–12% of blood cultures worldwide; however, recent studies from Europe and the USA presented inconsistent data regarding the prevalence of anaerobic bacteraemias between 1993 and 2006.The aims of this retrospective survey were to determine the prevalence of bacteraemias due to anaerobic bacteria and evaluate the importance of anaerobic blood cultures in a university hospital in Szeged, Hungary. We examined the occurrence of bacteraemias due to anaerobic bacteria during a 5-year period, from January 2005 to 2009, in order to identify current trends of anaerobic bacteraemias in our university.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Finegold SM (1977): Anaerobic Bacteria in Human Disease. Academic Press, New York

    Finegold S.M. , '', in Anaerobic Bacteria in Human Disease , (1977 ) -.

  • Washington JA II, Ilstrup DM: Blood cultures: issues and controversies. Rev Infect Dis 8, 792–802 (1986)

    Ilstrup D.M. , 'Blood cultures: issues and controversies ' (1986 ) 8 Rev Infect Dis : 792 -802.

    • Search Google Scholar
  • Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 271, 1598–1601 (1994)

    Wenzel R.P. , 'Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality ' (1994 ) 271 JAMA : 1598 -1601.

    • Search Google Scholar
  • Goldstein EJC: Anaerobic bacteremia. The secret pathogens. Journal of Clinical Anaerobic Infections 1, 12–15 (1995)

    Goldstein E.J.C. , 'Anaerobic bacteremia. The secret pathogens ' (1995 ) 1 Journal of Clinical Anaerobic Infections : 12 -15.

    • Search Google Scholar
  • Lombardi DP, Engleberg NC: Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 92, 53–60 (1992)

    Engleberg N.C. , 'Anaerobic bacteremia: incidence, patient characteristics, and clinical significance ' (1992 ) 92 Am J Med : 53 -60.

    • Search Google Scholar
  • Goldstein E: Anaerobic bacteremia. Clin Infect Dis 23(Suppl. 1), S97–S101 (1996)

    Goldstein E. , 'Anaerobic bacteremia ' (1996 ) 23 Clin Infect Dis : S97 -S101.

  • Lark RL, McNeil SA, VanderHyde K, Noorani A, Uberti J, Chenoweth C: Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients. Clin Infect Dis 33, 338–343 (2001)

    Chenoweth C. , 'Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients ' (2001 ) 33 Clin Infect Dis : 338 -343.

    • Search Google Scholar
  • Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV: Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 41, 3655–3660 (2003)

    Doern G.V. , 'Epidemiology and outcome of nosocomial and community-onset bloodstream infection ' (2003 ) 41 J Clin Microbiol : 3655 -3660.

    • Search Google Scholar
  • Raymond NJ, Blackmore TK, Humble MW, Jones MR: Bloodstream infections in a secondary and tertiary care hospital setting. Intern Med J 36, 765–772 (2006)

    Jones M.R. , 'Bloodstream infections in a secondary and tertiary care hospital setting ' (2006 ) 36 Intern Med J : 765 -772.

    • Search Google Scholar
  • Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y: A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect 12, 527–532 (2006)

    Glupczynski Y. , 'A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital ' (2006 ) 12 Clin Microbiol Infect : 527 -532.

    • Search Google Scholar
  • Wilson W, Martin W, Washington IIJ: Anaerobic bacteraemia. Mayo Clin Proc 47, 639–649 (1972)

    Washington I.I.J. , 'Anaerobic bacteraemia ' (1972 ) 47 Mayo Clin Proc : 639 -649.

  • Dorsher CW, Rosenblatt JE, Wilson WR et al.; Anaerobic bacteremia: decreasing rate over a 15 year period. Rev Infect Dis 13, 633–636 (1991)

    Wilson W.R. , 'Anaerobic bacteremia: decreasing rate over a 15 year period ' (1991 ) 13 Rev Infect Dis : 633 -636.

    • Search Google Scholar
  • Murray P, Traynor P, Hopson H: Critical assessment of blood culture techniques: analysis of recovery of obligate and facultative anaerobes, strict anaerobic bacteria, and fungi in aerobic and anaerobic blood culture bottles. J Clin Microbiol 30, 1462–1468 (1992)

    Hopson H. , 'Critical assessment of blood culture techniques: analysis of recovery of obligate and facultative anaerobes, strict anaerobic bacteria, and fungi in aerobic and anaerobic blood culture bottles ' (1992 ) 30 J Clin Microbiol : 1462 -1468.

    • Search Google Scholar
  • Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE: Reemergence of anaerobic bacteremia. Clin Infect Dis 44, 895–900 (2007)

    Rosenblatt J.E. , 'Reemergence of anaerobic bacteremia ' (2007 ) 44 Clin Infect Dis : 895 -900.

    • Search Google Scholar
  • Bengualid V, Singh H, Singh V, Berger J: An increase in the incidence of anaerobic bacteremia: true for tertiary care referral centers but not for community hospitals? Clin Infect Dis 46, 323–324 (2008)

    Berger J. , 'An increase in the incidence of anaerobic bacteremia: true for tertiary care referral centers but not for community hospitals? ' (2008 ) 46 Clin Infect Dis : 323 -324.

    • Search Google Scholar
  • Kornowski R, Schwartz D, Averbuch M, Levo Y, Berger S, Giladi M: Anaerobic bacteremia: a retrospective four-year analysis in general medicine and cancer patients. Infection 21(4), 241–244 (1993)

    Giladi M. , 'Anaerobic bacteremia: a retrospective four-year analysis in general medicine and cancer patients ' (1993 ) 21 Infection : 241 -244.

    • Search Google Scholar
  • Fenner L, Widmer AF, Straub C, Frei R: Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J Clin Microbiol 46, 2432–2434 (2008)

    Frei R. , 'Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period ' (2008 ) 46 J Clin Microbiol : 2432 -2434.

    • Search Google Scholar
  • Goldstein EJ, Citron DM: Annual incidence, epidemiology and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole and ceftizoxime of recent communityacquired isolates of the Bacteroides fragilis group. J Clin Microbiol 26, 2361–2366 (1988)

    Citron D.M. , 'Annual incidence, epidemiology and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole and ceftizoxime of recent communityacquired isolates of the Bacteroides fragilis group ' (1988 ) 26 J Clin Microbiol : 2361 -2366.

    • Search Google Scholar
  • Brook I: Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. J Infect Dis 160, 1071–1075 (1989)

    Brook I. , 'Anaerobic bacterial bacteremia: 12-year experience in two military hospitals ' (1989 ) 160 J Infect Dis : 1071 -1075.

    • Search Google Scholar
  • Gransden WR, Eykyn SJ, Phillips I: Anaerobic bacteremia: declining rate over a 15-year period. Rev Infect Dis 13(6), 1255–1256 (1991)

    Phillips I. , 'Anaerobic bacteremia: declining rate over a 15-year period ' (1991 ) 136 Rev Infect Dis : 1255 -1256.

    • Search Google Scholar
  • Peraino VA, Cross SA, Goldstein EJ: Incidence and clinical significance of anaerobic bacteremia in a community hospital. Clin Infect Dis 16, S288–S291 (1993)

    Goldstein E.J. , 'Incidence and clinical significance of anaerobic bacteremia in a community hospital ' (1993 ) 16 Clin Infect Dis : S288 -S291.

    • Search Google Scholar
  • Lombardi DP, Engleberg NC: Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 92(1), 53–60 (1992)

    Engleberg N.C. , 'Anaerobic bacteremia: incidence, patient characteristics, and clinical significance ' (1992 ) 92 Am J Med : 53 -60.

    • Search Google Scholar
  • Noriega LM, Van der Auwera P, Phan M, Daneau D, Meunier F, Gerain J, Aoun M: Anaerobic bacteremia in a cancer center. Support Care Cancer 1(5), 250–255 (1993)

    Aoun M. , 'Anaerobic bacteremia in a cancer center ' (1993 ) 1 Support Care Cancer : 250 -255.

    • Search Google Scholar
  • Ramos JM, García-Corbeira P, Fernández-Roblas R, Soriano F: Bacteremia caused by anaerobes: analysis of 131 episodes. Enferm Infec Microbiol Clin 12(1), 9–16 (1994)

    Soriano F. , 'Bacteremia caused by anaerobes: analysis of 131 episodes ' (1994 ) 12 Enferm Infec Microbiol Clin : 9 -16.

    • Search Google Scholar
  • Arzese A, Trevisan R, Menozzi MG: Anaerobe-induced bacteremia in Italy: a nationwide survey. The Italian Anaerobe Study Group. Clin Infect Dis 20, S230–S232 (1995)

    Menozzi M.G. , 'Anaerobe-induced bacteremia in Italy: a nationwide survey. The Italian Anaerobe Study Group ' (1995 ) 20 Clin Infect Dis : S230 -S232.

    • Search Google Scholar
  • Salonen JH, Eerola E, Meurman O: Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis 26, 1413–1417 (1998)

    Meurman O. , 'Clinical significance and outcome of anaerobic bacteremia ' (1998 ) 26 Clin Infect Dis : 1413 -1417.

    • Search Google Scholar
  • Anuradha DE, Saraswathi K, Gogate A: Anaerobic bacteraemia: a review of 17 cases. J Postgrad Med 44, 63–66 (1998)

    Gogate A. , 'Anaerobic bacteraemia: a review of 17 cases ' (1998 ) 44 J Postgrad Med : 63 -66.

    • Search Google Scholar
  • Blairon L, De Gheldre Y, Delaere B, Sonet A, Bosly A, Glupczynski Y: A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect 12, 527–532 (2006)

    Glupczynski Y. , 'A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital ' (2006 ) 12 Clin Microbiol Infect : 527 -532.

    • Search Google Scholar
  • Muttaiyah S, Paviour S, Buckwell L, Roberts SA: Anaerobic bacteraemia in patients admitted to Auckland City Hospital: its clinical significance. N Z Med J 120(1265):U2809 (2007)

    Roberts S.A. , 'Anaerobic bacteraemia in patients admitted to Auckland City Hospital: its clinical significance ' (2007 ) 120 N Z Med J : U2809 -.

    • Search Google Scholar
  • Saito T, Senda K, Takakura S, Fujihara N, Kudo T, Linuma Y, Fujita N, Komori T, Baba N, Horii T, Matsuoka K, Tanimoto M, Ichiyama S: Anaerobic bacteremia: the yield of positive anaerobic blood cultures: patient characteristics and potential risk factors. Clin Chem Lab Med 41, 293–297 (2003)

    Ichiyama S. , 'Anaerobic bacteremia: the yield of positive anaerobic blood cultures: patient characteristics and potential risk factors ' (2003 ) 41 Clin Chem Lab Med : 293 -297.

    • Search Google Scholar
  • Iwata K, Takahashi M: Is anaerobic blood culture necessary? If so, who needs it? Am J Med Sci 336, 58–63 (2008)

    Takahashi M. , 'Is anaerobic blood culture necessary? If so, who needs it? ' (2008 ) 336 Am J Med Sci : 58 -63.

    • Search Google Scholar
  • Hecht DW: Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. Anaerobe 12, 115–121 (2006)

    Hecht D.W. , 'Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing ' (2006 ) 12 Anaerobe : 115 -121.

    • Search Google Scholar
  • Nagy E, Urbán E, CE Nord: Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. CMI 17, 371–379 (2011)

    Urbán E. , 'CE Nord: Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience ' (2011 ) 17 CMI : 371 -379.

    • Search Google Scholar
  • Wybo I, Piérard D, Verschraegen I: Third Belgian multi-centre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 59, 132–139 (2007)

    Piérard D. , 'Verschraegen I: Third Belgian multi-centre survey of antibiotic susceptibility of anaerobic bacteria ' (2007 ) 59 J Antimicrob Chemother : 132 -139.

    • Search Google Scholar
  • Betriu C, Culebras E, Gómez M: Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Antimicrob Agents Chemother 52, 2686–2690 (2008)

    Gómez M. , 'Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain ' (2008 ) 52 Antimicrob Agents Chemother : 2686 -2690.

    • Search Google Scholar
  • Brazier J, Chmelar D, Dubreuil L, Feierl G, Hedberg M, Kalenic S, Könönen E, Lundgren B, Malamou-Ladas H, Nagy E, Sullivan A, Nord CE: European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci. Int J Antimicrob Agents 31(4), 316–320 (2008)

    Nord C.E. , 'European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci ' (2008 ) 31 Int J Antimicrob Agents : 316 -320.

    • Search Google Scholar
  • Sóki J, Gal M, Brazier JS, Rotimi VO, Urbán E, Nagy E, Duerden BI: Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. J Antimicrob Chemother 57, 212–220 (2006)

    Duerden B.I. , 'Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains ' (2006 ) 57 J Antimicrob Chemother : 212 -220.

    • Search Google Scholar
  • Sóki J, Gonzalez SM, Urbán E, Nagy E, Ayala JA: Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains. J Antimicrob Chemother 66, 2492–2500 (2011)

    Ayala J.A. , 'Molecular analysis of the effector mechanisms of cefoxitin resistance among Bacteroides strains ' (2011 ) 66 J Antimicrob Chemother : 2492 -2500.

    • Search Google Scholar
  • Bartha NA, Sóki J, Urbán E, Nagy E: Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations. Int J Antimicrob Agents 38(6), 522–525 (2011)

    Nagy E. , 'Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations ' (2011 ) 386 Int J Antimicrob Agents : 522 -525.

    • Search Google Scholar
  • Toprak NU, Uzunkaya OD, Sóki J, Soyletir G: Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital. Anaerobe 18(1), 169–171 (2012)

    Soyletir G. , 'Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital ' (2012 ) 181 Anaerobe : 169 -171.

    • Search Google Scholar
  • Fernández-Canigia L, Litterio M, Legaria MC, Castello L, Predari SC, Di Martino A, Rossetti A, Rollet R, Carloni G, Bianchini H, Cejas D, Radice M, Gutkind G: First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to Carbapenems in Argentina. Antimicrob Agents Chemother 56(3), 1309–1314 (2012)

    Gutkind G. , 'First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to Carbapenems in Argentina ' (2012 ) 56 Antimicrob Agents Chemother : 1309 -1314.

    • Search Google Scholar

Language: English

Founded in 2011
Publication: One volume of four issues annually

Publication Programme: 2020. Vol. 10. (Online Only)

Article Processing Charge: EUR 600.00 (for discounts see the Open Access menu)

Indexing and Abstracting Services:

  • Arts and Humanities Citation Index
  • DOAJ
  • EMBASE

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita

Editor(s)-in-Chief: Heimesaat, Markus M.

Vice Editor(s)-in-Chief: Fuchs, Anja

Editorial Board

Chair of the Editorial Board:
Jeffrey S. Buguliskis (Thomas Jefferson University, USA)

  • Jörn Albring (University of Münster, Germany)
  • Stefan Bereswill (Charité - University Medicine Berlin, Germany)
  • Dunja Bruder (University of Megdeburg, Germany)
  • Jan Buer (University of Duisburg, Germany)
  • Jeff Buguliskis (Thomas Jefferson University, USA)
  • Edit Buzas (Semmelweis University, Hungary)
  • Charles Collyer (University of Sydney, Australia)
  • Renato Damatta (UENF, Brazil)
  • Ivelina Damjanova (Semmelweis University, Hungary)
  • Maria Deli (Biological Research Center, HAS, Hungary)
  • Olgica Djurković-Djaković (University of Belgrade, Serbia)
  • Jean-Dennis Docquier (University of Siena, Italy)
  • Anna Erdei (Eötvös Loránd University, Hungary)
  • Zsuzsanna Fabry (University of Washington, USA)
  • Beniam Ghebremedhin (Witten/Herdecke University, Germany)
  • Nancy Guillen (Institute Pasteur, France)
  • Georgina L. Hold (University of Aberdeen, United Kingdom)
  • Ralf Ignatius (Charité - University Medicine Berlin, Germany)
  • Zsuzsanna Izsvak (MDC-Berlin, Germany)
  • Achim Kaasch (University of Cologne, Germany)
  • Tamás Laskay (University of Lübeck, Germany)
  • Oliver Liesenfeld (Roche, USA)
  • Shreemanta Parida (Vaccine Grand Challenge Program, India)
  • Matyas Sandor (University of Wisconsin, USA)
  • Ulrich Steinhoff (University of Marburg, Germany)
  • Michal Toborek (University of Miami, USA)
  • Mary Jo Wick (University of Gothenburg, Sweden)
  • Susanne A. Wolf (MDC-Berlin, Germany)

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildikodunay@gmail.com
You can find more information at http://eujmi.com

The author instruction is available in PDF.
Please, download the file from HERE.

 

MANUSCRIPT SUBMISSION